Cognitive deficits in multiple sclerosis: A systematic review;Déficits cognitivos na esclerose múltipla: Uma revisão sistemática

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 4, 2010, Pages 632-641

  Ferreira, Maria Lúcia Brito ^a  

^a HOSPITAL DA RESTAURAÇÃO   (Brazil)

Author keywords

Cognitive dysfunctions; Multiple sclerosis; Neuropsychological batteries

Indexed keywords

ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONSENSUS; DIAGNOSTIC TEST; HUMAN; MEMORY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 77957309142     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/s0004-282x2010000400029     Document Type: Review

References (41)

1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-1151.
2. Winkelmann A, Engel C, Apel C, Zettl UK. Cognitive impairment in Multiple Sclerosis. J Neurol 2007;254(Suppl 2):S35-S42.
3. Amato MP, Portaccio E, Zipoli V. Are the protective treatments for cognitive decline in MS? J Intern Neurol Scien 2006;245:183-186.
4. Engel C, Greim B, Zettl UK. Diagnostics of cognitive dysfunctions in multiple sclerosis. J Neurol 2007;254(Suppl 2):S30-S34.
5. Schulz D, Kopp B, Kunkel A, Faiss JH. Cognition in the stage multiple sclerosis. J Neurol 2006;253:1002-1010.
6. Barco AN, López MPS, Ribal JB, Pérez TO, Pérez MÁH. Alteraciones cognitivas en etapas iniciales de la esclerosis múltiple y su relación con el estado de ánimo, variables demográficas y clínicas. Psicothema 2008;20:583-588.
7. Arnett P, Forn C. Evaluación neuropsicológica en la esclerosis múltiple. Rev Neurol 2007;44:166-172.
8. Amato MP, Portaccio E, Zipoli V. Are the protective treatments for cognitive decline in MS? J Intern Neurol Sci 2006;245:183-186.
9. Diamond BJ, Johnson SK, Kaufman M, Graves L. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol 2008;23:189-199.
10. Scherer P, Penner IK, Rohr A, et al. The faces symbol test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study. Multiple Sclerosis 2007;13:402-411.
11. Huijbregts SCJ, Kalkers NF, Sonneville LMJ, Groot V, Polman CH. Cognitive impairment and decline in different MS subtypes. J Neurol Sci 2006;245:187-194.
12. Griffiths SY, Yamamoto A, Boudreau VG, Ross LK, Kozora E, Thornton AE. Memory interference in multiple sclerosis. JINS 2005;11:737-746.
13. Andrade VM, Bueno OFA, Oliveira MGM, Oliveira ASB, Oliveira EML, Miranda MC. Cognitive profile of patients with relapsing remitting multiple sclerosis. Arq Neuropsiquiatr 1999;57:775-783.
14. Balsimelli S, Mendes MF, Bertolucci PHF, Tilbery CP. Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity. Arq Neuropsiquiatr 2007;65:262-267.
15. Benedict RHB. Effects of using same - versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis. J Intern Neuropsychol Soc 2005;11:727-736.
16. Dineen RA, Vilisaar J, Hlinka J, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009;132:239-249.
17. Potagas C, Giogkaraki E, Koutsis G, et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008;267:100-106.
18. Arango-Lasprilla JC, de Luca J, Chiaravalloti N. El perfil neuropsicológico en la esclerosis múltiple. Psicothema 2007;19:1-6.
19. Jønsson A, Andresen J, Storr L, Tscherning T, Sørensen PS, Ravnborg M. Cognitive impairment in newly diagnosed multiple sclerosis patients: A 4-year follow-up study. J Neurol Sci 2006;245:77-85.
20. Christodoulou C, Melville P, Scherl WF, et al. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis. J Intern Neuropsychol Soc 2005;11:614-619.
21. Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE, Krupp LB. Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 2006;245:127-136.
22. Mathiesen HK, Jønsson A, Tscherning T, et al. Correlation of global N-Acetyl aspartate with cognitive impairment in multiple sclerosis. Arch Neurol 2006; 63:533-536.
23. Penner IK, Kappos L, Rausch M, Opwis K, Radü EW. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI. J Physiol 2006;99: 455-462.
24. Randolph JJ, Wishart HA, Saykin AJ, et al. FLAIR lesion in multiple sclerosis: relation to processing speed and verbal memory. J Intern Neuropsychol Soc 2005;11:205-209.
25. Foong J, Rozewicz L, Quaghebeur G, et al. Executive function in multiple sclerosis the role of frontal lobe pathology. Brain 1997;120:15-26.
26. Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008;28;164-171.
27. Mesaros S, Rocca MA, Riccitelli G, et al. Corpus callosum damage and cognitive dysfunction in begin MS. Human Brain Mapping 2009;30:2656-2666.
28. Morgen K, Sammer G, Courtney SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage 2006;30:891-898.
29. Nebel K, Wiese H, Seyfarth J, et al. Activity of attention related structures in multiple sclerosis. Brain Res 2007;1151:150-160.
30. Barak Y, Achiron A. Effect of Interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 2002;47:11-14.
31. Achiron A, Barak Y. Cognitive changes in early MS: a call for a common frame work. J Neurol Sci 2006;245:47-51.
32. Beatty WW. Cognitive dysfunction in multiple sclerosis: natural history and impact on productive living. Ital J Neurol Scien 1998;19(Suppl): S381-S387.
33. Benedict RHB, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol 2007;254(Suppl 2): S22-S25.
34. Malik AB, Turner ME, Sadler C. Neuropsychological evaluation. eMedicine 2009. Disponível em: http://www.emedicine.medscape.com/article/317596-print. Acesso em: 24/09/2009.
35. Izquierdo I. Memória. Porto Alegre: Artmed 2002.
36. Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci 2007;14:919-927.
37. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Oxford: Update Software. The Cochrane Library 2006.
38. Zakzanis K. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 2000;15:115-136.
39. Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis. CNS Drugs 2002;16:445-455.
40. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004; 49:157-163.
41. Benedict RHB, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis. J Intern Neuropsychol Soc 2006; 12:549-558.